AAV Isomerohydrolase Potency Assay with Non-Radioactive Mass Spectrometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring isomerohydrolase activity are limited by the use of radioactive substrates, which pose safety and handling challenges, and lack precision and accuracy in quantifying the reaction products.
Innovation Solution
A non-radioactive method using a viral vector encoding an isomerohydrolase protein, such as RPE65, is developed, where cells are transduced with an AAV vector, the protein is expressed, and the reaction product is quantified by mass spectrometry after column chromatography, allowing for precise measurement of isomerohydrolase activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radioactive substrates are used to measure isomerohydrolase activity, then the measurement can be performed, but safety concerns and handling challenges arise
Solution Approach 1:
The patent converts the harmful radioactive substrate into a beneficial non-radioactive substrate that can still be detected through mass spectrometry. The harmful radioactivity is replaced with a safe molecular structure that retains the substrate's functional properties while enabling detection through a different, safer mechanism (mass spectrometric detection of reaction products).
Solution Approach 2:
The patent replaces the radioactive detection mechanism with a mass spectrometry-based detection system. Instead of measuring radioactivity, the system uses mass spectrometry to detect and quantify the reaction products formed from the non-radioactive substrate, substituting a mechanical/physical detection method for a chemical/radiological one.
2Measurement precision
If traditional methods are used to quantify reaction products, then measurement is possible, but precision and accuracy are insufficient
Solution Approach 1:
The patent changes the detection parameter from radioactive signal intensity to mass-to-charge ratio and product concentration. By measuring the mass spectrometric parameters of reaction products (molecular weight, fragmentation patterns, concentration) rather than radioactive decay, the system achieves superior precision and accuracy in quantifying isomerohydrolase activity.
3Object-affected harmful factors
If a non-radioactive method with mass spectrometry is used, then safety concerns are resolved, but the device complexity increases
Solution Approach 1:
The patent introduces column chromatography as an intermediary step between the enzymatic reaction and mass spectrometry detection. This intermediary purification step separates the reaction products from the complex cellular extract, simplifying the subsequent mass spectrometry analysis by reducing matrix interference and improving detection sensitivity, thereby offsetting some of the inherent complexity of the mass spectrometry system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides accurate and precise measurement of isomerohydrolase activity, overcoming safety concerns and enhancing the reliability of quantification, suitable for both drug substance and drug product testing.
Implementation Method 1
isomerohydrolase activity or potency can be measured by quantifying reaction products produced by such enzymes
Implementation Method 2
subjecting the reaction product to column (liquid) chromatography thereby producing a column (liquid) chromatography purified reaction product
Implementation Method 3
subjecting said column (liquid) chromatography purified reaction product to mass spectrometry thereby quantifying the reaction product
Data Source
AI summary
Methods for assaying function and/or activity and/or potency of isomerohydrolase proteins are provided.